Publication: 878

Publication: 878

Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI).

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Br J Haematol vol 151 (2) 143-51

Year:: 2010
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: CCP
Primary Committee:: Older Adult
Sec. Committees:: Health Outcomes

Pharmas:
Grants:: CA11083, CA13650, CA16450, CA21115, CA23318, CA32291, CA35431, CA66636, U10 CA011083, U10 CA013650, U10 CA021115, U10 CA023318, U10 CA032291, U10 CA035431, U10 CA066636, U24 CA114737

Corr. Author:
Authors:: Ranjana H Advani Haiyan Chen Thomas M Habermann Vicki A Morrison Edie A Weller Richard I Fisher Bruce A Peterson Randy D Gascoyne Sandra J Horning

Networks:

Study: Alliance-9793
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:

Keywords:: Age Factors, Aged, Aged, 80 and over, Antibodies, Monoclonal, Murine-Derived, Antineoplastic Combined Chemotherapy Protocols, Cyclophosphamide, Doxorubicin, Drug Administration Schedule, Epidemiologic Methods, Health Status Indicators, Humans, Lymphoma, Large B-Cell, Diffuse, Middle Aged, Prednisone, Prognosis, Treatment Outcome, Vincristine